CONTEXT: Proteases play a key role in cancer progression because of their involvement in the degradation of the extracellular matrix and basement membranes. In breast cancer, increased expression of cathepsin-B and other thiol proteases has been associated with increased aggressiveness and poor outcomes. Protease-sensing optical probes have been used in a variety of oncologic imaging applications. Dr. Christoph Bremer and colleagues at Massachusetts General Hospital and the University of Muenster in Germany examined the ability of a cathepsin-sensing fluorescent imaging probe to detect spontaneous breast cancer lesions.
RESULTS: Transgenic mice that spontaneously develop breast cancer were injected with a cathepsin-sensing imaging probe. Fluorescence reflectance imaging (FRI) and fluorescence-mediated tomography (FMT) were performed 24 hours after injection. MR images were obtained for anatomic coregistration with FMT. Both FRI and FMT imaging clearly delineated tumor nodules. Immunohistochemistry confirmed cathepsin-B expression by primary tumors.
IMAGE: FMT images were acquired at different levels in the tumor region, as illustrated in the corresponding sagittal MR images (left). After injection of the optical probe, strong tissue fluorescence could be reconstructed in the tumor region (right).
IMPLICATIONS: Because the expression of various proteases correlates with patient outcome, FRI and FMT with protease-sensing optical probes may offer a means of breast cancer detection. The imaging techniques may also be useful in noninvasive differentiation of breast tumors and may have application in the monitoring of treatment with protease inhibitors.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.